In this study, we report the preparation and characterization of the PVA-DTPA-Gd conjugate as a potential MRI contrast agent (CA). The r 1 value and the r 2/r 1 ratio were about 5.6 mM-1 s-1 and 1.31, respectively. In vitro toxicity studies not only demonstrated that the polymeric system possessed good biocompatibility, but also proved that the conjugate could be an attractive candidate for CA.
This journal is © The Royal Society of Chemistry.